Skip to content

Clinical study of early perioperative use of Houpo Paiqi Heji for rapid postoperative recovery of day surgery patients

Clinical study of early perioperative use of Houpo Paiqi Heji for rapid postoperative recovery of day surgery patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075331
Enrollment
Unknown
Registered
2023-09-01
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Day surgery

Interventions

Group 1:Patients were given 50 ml of Houpo Paiqi Heji orally as soon as they met the criteria for oral intake within 6 hours after surgery and again 4 hours after that time point.
Group 2:Patients were given 50 ml of Houpo Paiqi Heji orally as soon as they met the criteria for oral intake after 6 hours postoperatively and again 4 hours after that time point.

Sponsors

First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Elective day surgery is to be performed, and the disease types and operation methods meet the admission criteria for day surgery; 2. Aged 18-80 years; 3. American Society of Anesthesiologists (ASA) Grade ? or ?; 4. No serious complications, normal liver and kidney function before operation, no significant damage to cardiopulmonary function. 5. Patients fully understand the purpose and significance of this trial, voluntarily participate in this clinical trial, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.Does not meet the admission criteria for day surgery; 2.Upper and lower abdominal surgery; 3.Preoperative abnormal liver and kidney function, suspected chronic liver disease or common bile duct disease; 4.Preoperative administration of drugs or related operations that may affect liver and kidney function; 5.Abnormal evaluation of gastrointestinal function before surgery; 6.Other surgical treatment was required due to the condition during the operation; 7.Severe intraoperative/postoperative complications occurred; 8.Uncooperative communicators; 9.Contraindications of Houpo Paiqi Heji.

Design outcomes

Primary

MeasureTime frame
blood pressure;heart rate;SPO2;body temperature;VAS pain grade;Recovery time and number of bowel sounds;First exhaust/defecation time;liver function;renal function;electrolytes;twelve cytokine tests;24-hour adverse events;

Secondary

MeasureTime frame
time of oral intake;first time out of bed;QoR15;Patient satisfaction;

Countries

China

Contacts

Public ContactXiaopeng Mei

First Affiliated Hospital of Xi'an Jiaotong University

meixpxp126@126.com+86 181 6192 9067

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026